In this context, Bacos et al. [87] demonstrated that blood-borne epigenetic marks reflect age-related DNA methylation changes in human islets, and that altered methylation at certain genes are associated with the future insulin-secreting capacity and future risk of T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.